How a weird blue dye saves liver cells from drug combo damage

Original Title

Bypassing the compromised mitochondrial electron transport with methylene blue alleviates efavirenz/isoniazid-induced oxidant stress and mitochondria-mediated cell death in mouse hepatocytes

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

Two common drugs, when taken together, can accidentally break a cell’s power plant. But a blue dye called methylene blue can jump over the broken parts and keep the power flowing.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

Neither drug alone caused cell death—even at high concentrations (efavirenz up to 30 μM, isoniazid up to 1000 μM).

Common belief is that drug toxicity is dose-dependent and additive; here, toxicity is synergistic and only appears when both drugs are present, suggesting a hidden threshold effect.

Practical Takeaways

If you or someone you know is on both efavirenz and isoniazid, ask your doctor about liver enzyme monitoring and whether methylene blue could be considered as a protective agent in future clinical trials.

medium confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.

12%
Lower QualityOverall Score

Publication

Journal

Redox Biology

Year

2014

Authors

Kang Kwang Lee, U. Boelsterli

Open Access
52 citations
Analysis v1